Ottawa, Canada – March 15, 2018 – CannaRoyalty Corp. (CSE:CRZ) (OTCQX:CNNRF) (“CannaRoyalty” or the “Company”) announced today that it has entered into an agreement with a syndicate of [...]
CannaRoyalty (CR) is a fully integrated, active investor and operator in the legal cannabis sector. Our focus is to build and support a diversified portfolio of growth-ready assets in high-value segments of the cannabis sector, including research, consumer brands, devices and intellectual property.
CannaRoyalty’s management team combines a hands-on understanding of the cannabis industry with seasoned financial know-how, assembling a platform of holdings via royalty agreements, equity interests, secured convertible debt and licensing agreements.
We invest in promising companies, brands, projects and assets in the United States, Canada and globally. As a strategic partner, our contribution includes capital, branding and functional expertise to advance commercialization and maximize return potential.
CannaRoyalty Corp. is trading on the Canadian Securities Exchange (CSE) under the stock symbol “CRZ” and in the US on the OTC under the stock symbol “CNNRF”. CannaRoyalty’s first day of public trading on the CSE was December 8, 2016. Live updates are available here. Please contact your broker if you wish to purchase shares in the company.
Currently, our platform of diversified holdings includes royalty agreements, equity interests, secured convertible debt, and licensing agreements in various businesses in Canada and the U.S.
This encompasses the medical and adult use cannabis sector and includes research, brands and devices, as well as other strategic investments.
To learn more about CR’s individual portfolio companies, please click here or on any of the categories below.
RESEARCH/IP : Developing intellectual property and patents in cutting-edge science, targeting health and wellness applications.
CR BRANDS : A premium positioned stable of consumer brands in medical, wellness, and animal health.
INFRASTRUCTURE : Industry infrastructure built to support and accelerate the commercialization of CannaRoyalty assets.
Yes. To date, our Canadian holdings and interests include Bodhi Research & Development Inc. and Resolve Digital Health.
Bodhi Research (Ontario) is a collaboration to explore the use of cannabis in the treatment of concussions and post-concussive syndrome with foremost expert in concussions, Dr. Neilank Jha (Neurosurgeon and Founder of Konkussion – the largest network of concussion clinics in North America). Research trials pending.
Resolve Digital Health (Toronto, Ontario) develops proprietary smart technology for the cannabis industry. Resolve’s Breeze Inhaler system is the world’s first smart inhaler with metered and monitored dosing technology, plus health program support and health team interconnectivity. Breeze Inhaler technology connects with the user’s smart phone via bluetooth to deliver rich information and integrated care.
CannaRoyalty has also acquired Electric Medialand (Ottawa, Ontario), an established full service digital marketing agency. Electric Medialand brings extensive expertise in cannabis sector marketing, branding and sales to support CannaRoyalty’s brands, drive commercialization and grow sales.
Meet CannaRoyalty’s CEO Marc Lustig and read the CRHC management team and board member bios here.
Our investment strategy involves royalty agreements, equity stakes, secured convertible debt and licensing agreements. An explanation of these investment categories, and relevant examples in relation to our business, is available here.
Please consult with your broker to determine whether you are eligible to invest.
California, Florida, Washington (State), Oregon, Colorado and Arizona.
The US market is forecast to grow from $7.2 billion USD in 2016 to $22.8 billion by 2020 (ArcView Market Research). The 2026 Forecast is $50 billion (Cowen & Co.). In California alone (where CannaRoyalty has 8 holdings), the market is forecast to grow from its current $2.7 Billion to $6.6 billion by 2020 (ArcView Market Research).
You can subscribe to receive news and updates here.